Sasidharan Taravath, MD
Neurology with Special Qualifications in Child Neurology · Jacksonville, NCNPI 1851353718
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,542 of the $5,909 with a category attached, or 76.9%. 49 manufacturers reported payments, led by Livanova USA, Inc. at 25.5% of the total. 2025 is the largest year on record at $2,753, 3.0 times the $927 reported in 2019.
Across 218 payments — averaging $27.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$2K
- Jazz Pharmaceuticals Inc.$367
- AstraZeneca$344
- Neurelis, Inc.$291
- Supernus Pharmaceuticals, Inc.$278
- TG Therapeutics, Inc.$277
- plus $3K from 43 others
What the payments were for
- Travel & lodging$87215%
- Food & beverage$4,54277%
- Education$4948%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,909 in reported general payments places this provider in the 80th percentile of 46 neurology with special qualifications in child neurology providers in North Carolina.
See all neurology with special qualifications in child neurology providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levetiracetam | 15 | $366 |
| Donepezil Hcl | 21 | $255 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 11 | $188 |
| Divalproex Sodium ErDivalproex Sodium | 17 | $144 |
| Quetiapine Fumarate | 11 | $105 |
| Primidone | 11 | $103 |
| Clonazepam | 13 | $73 |
| Topiramate | 12 | $62 |
Paid to pharmacies, not to this prescriber.
Other neurology with special qualifications in child neurology in Jacksonville
- Michael HofmannJacksonville$327
- Natalie KatzDurham$60K
- Shana WallaceCharlotte$58K
- Kevin RathkeDurham$39K
- Robert NahouraiiConcord$37K
- Shalaka IndulkarFayetteville$19K
- Khaled JreisatWilmington$13K
- Traci SheafferRaleigh$9K
- Danielle WyantDurham$9K
- Virinder NohriaFranklin$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.